Phase 4Status unknownAge-related condition

Kronos Early Estrogen Prevention Study (KEEPS)

Effects of Estrogen Replacement on Atherosclerosis Progression in Recently Menopausal Women

Sponsor
Kronos Longevity Research Institute (Academic or other)
Enrollment
728 planned
Conditions
Menopause; Arteriosclerosis
Interventions
Conjugated equine estrogens 0.45 mg/day; Transdermal estradiol, 50 mcg/day; Micronized progesterone, 200 mg/day x 12 d/month; CEE , progesterone, estradiol patch or placebo for each; CEE, progesterone, transdermal patch or the placebo
Ages
adults
Registry
NCT00154180

Full record on ClinicalTrials.gov

From the registry

The study will examine the effects of estrogen and progesterone on the development of atherosclerosis in menopausal women when hormone treatment is initiated within 3 years of the menopausal transition.

Primary outcomes

  • Rate of change of carotid intimal medial thickness by ultrasound

History

  1. Study completion

  2. Primary completion

  3. Last registry update

  4. Started

  5. Registered

Papers citing this trial